Agency for Science, Technology and Research
A*STAR
Agency for Science, Technology and Research (A*STAR) is a Singaporean government research agency that both incubates and invests in technology companies. Per a 2021 Gaorong Ventures piece, it incubated Mirxes in 2010 from a microRNA research group, helping commercialize PCR-based cancer early-detection technology . In 2023, an A*STAR affiliate also joined Mirxes's $50 million Series D as an investor, alongside EDBI, Mitsui & Co., and others . The agency appears in elsewhere's corpus primarily through its role in Singapore's biomedical and deep-tech startup pipeline, rather than as a standalone profile subject.
AI-generated — may contain errors, please verify.
Coverage
Healthcare and chip companies close new funding rounds; satellite communications, energy storage batteries, and other sectors hit milestones | Rongbao · July
Foresight and courage.
高榕创投·Mirxes Completes $50 Million Series D to Accelerate Cancer Early-Screening Pipeline R&D and Commercialization
Focused on innovative blood-based early screening products and services for cancer.
高榕创投·"Tiny but Mighty" miRNA: How Cancer Can Be Caught at Its Earliest Stage | Gaorong Ventures "Future"
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
高榕创投·
